LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

INTRODUCTION: The association of polymorphisms in molecules involved in the immune response (checkpoint inhibitors) with the clinical outcome after allogeneic transplantation (alloHSCT) has been described. Lymphocyte Activation 3 (LAG3) is a surface protein that plays a regulatory role in immunity a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, David, Rodríguez-Romanos, Rocío, González-Bartulos, Marta, García-Cadenas, Irene, de la Cámara, Rafael, Heras, Inmaculada, Buño, Ismael, Santos, Nazly, Lloveras, Natàlia, Velarde, Pilar, Tuset, Esperanza, Martínez, Carmen, González, Marcos, Sanz, Guillermo F., Ferrá, Christelle, Sampol, Antonia, Coll, Rosa, Pérez-Simón, Jose A., López-Jiménez, Javier, Jurado, Manuel, Gallardo, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897054/
https://www.ncbi.nlm.nih.gov/pubmed/36742309
http://dx.doi.org/10.3389/fimmu.2023.1066393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897054/
https://www.ncbi.nlm.nih.gov/pubmed/36742309
http://dx.doi.org/10.3389/fimmu.2023.1066393

Ejemplares similares